期刊文献+

转酮醇酶1在人结肠癌细胞株LoVo增殖中的作用 被引量:3

Effect of Transketolase-Like-1 on Proliferation of Human Colon Cancer Cell Line LoVo
下载PDF
导出
摘要 目的探讨转酮醇酶1(TKTL1)在体外培养的人类结肠癌细胞株(LoVo)生长增殖中的作用。方法构建针对TKTL1 mRNA的小干扰RNA(siRNA)质粒,将该质粒转染LoVo细胞;采用实时定量RT-PCR检测转染前后LoVo细胞转酮醇酶基因家族中转酮醇酶(TKT)、TKTL1、转酮醇酶2(TKTL2)mRNA表达水平的变化,通过流式细胞术和MTT法检测转染前后LoVo细胞周期和细胞增殖的改变。结果转染组(携带有pEGFP-C1-U6/TKTL1)、质粒对照组(携带有pEGFP-C1-U6/UC)和未转染组(未转染细胞)中TKT和TKTL2 mRNA的表达水平差异无显著性意义(P>0.05)。转染组细胞中TKTL1的表达水平与质粒对照组和未转染组相比,明显下调,且转染组LoVo细胞总转酮醇酶活性明显下降,细胞增殖明显被抑制,LoVo细胞被阻滞在G0/G1期。结论TKTL1在人类结肠癌细胞(LoVo细胞系)的生长增殖中起重要作用,TKTL1可能成为肿瘤治疗的新靶点。 Objective To investigate the effect of transketolase-like-1 (TKTL1) on proliferation of human colon cancer cell line LoVo cells in vitro. Methods siRNA plasmid against gene TKTL1 (pEGFP-C1-U6/TKTL1) was constructed and transfected into LoVo cells. The expression of TKT gene family members TKT, TKTL1 and TKTL2 mRNA was detected by realtime PCR in LoVo cells before and after transfection. The changes in proliferation and cell cycle of LoVo cells were assayed by MTT and flow cytometry before and after transfection. Results There was no significant difference in the expression level of TKT and TKTL2 among transfected cells, untransfected cells and plasmid control cells (P〉0.05). The TKTL1 expression in transfected cells was decreased significantly as compared with that in untransfected cells and plasmid control cells. In transfected cells, the total transketolase activity was down-regulated, cell proliferation was inhibited and cells were arrested in G0/G1 phase. Conclusion TKTL1 plays an important role in the total transketolase activity and in cell proliferation of human colon cancer.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2008年第3期347-350,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 湖北省自然科学基金资助项目(No2004ABA189)
关键词 转酮醇酶 转酮醇酶1 小干扰RNA 转酮醇酶活性 LOVO细胞 transketolase transketolase-like gene 1 small interfering RNA tansketolase activity LoVo cell line
  • 相关文献

参考文献12

  • 1RAMANATHAN A,WANG C, SCHREIBER S L. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements[J]. Proc Natl Acad Sci USA, 2005, 102 (17):5992-5997.
  • 2BOROS L G, BRANDES J L, YUSUF F I, et al. Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action [J]. Med Hypotheses, 1998, 50(6) :501-506.
  • 3SOLOVJEVA O N, KOCHETOV G A. Inhibition of transketolase by p-hydroxyphenylpyruvate [J]. FEBS Lett, 1999, 462(3) :246-248.
  • 4COY J F, DRESSLER D, WILDE J, et al. Mutations in the transketolase-like gene TKTL1 ; clinical implications for neurodegenerative diseases, diabetes and cancer[J]. Clin Lab, 2005, 51(5/6): 257-273.
  • 5ZHANG S, YANG J H,GUO C K,et al. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells [J]. Cancer Lett, 2007, 253(1):108-114.
  • 6WENG G, BHALLA U S, IYENGER R. Complexity in biological signaling systems [J]. Science, 1999, 284(5411):92- 96.
  • 7BOROS L G, PUIGJANER J, CASCANTE M, et al. Oxyth-iamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation [J]. Cancer Res, 1997, 57(19): 4242-4248.
  • 8RAIS B, COMIN B, PUIGJANER J, et al. Oxythiamine and dehydro-epiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumour cells through inhibition of the pentose cycle [J]. FEBS Lett, 1999, 456(1): 113-118.
  • 9LANGBEIN S, ZERILLI M, ZUR HAUSEN A, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted[J]. Br J Cancer, 2006, 94(4) :578-585.
  • 10COMIN-ANDUIX B, BOREN J, MARTINEZ S, et al. The effect of thiamine supplementation on tumour proliferation: A metabolic control analysis study [J]. Eur J Biochem, 2001, 268(15) : 4177-4182.

同被引文献34

  • 1张德太,胡丽华,杨渝珍.脱氢表雄酮对体外培养Burkit淋巴瘤细胞抗氧化能力影响的研究[J].医学研究生学报,2005,18(9):776-778. 被引量:7
  • 2张德太,胡丽华,杨渝珍.去氢表雄酮及G6PD基因反义寡核苷酸对Raji细胞的某些影响[J].中国病理生理杂志,2006,22(12):2397-2400. 被引量:4
  • 3Kayser G,Sienel W,Kubitz B,et al.Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression[J].Pathology,2011,43(7):719-724.
  • 4Yuan W,Wu S,Guo J,et al.Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo[J].Cancer Biol Ther,2010,9(9):710-716.
  • 5Fr(o)hlich E,Fink I,Wahl R.Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines[J].Invest New Drugs,2009,27(4):297-303.
  • 6Schmidt M,Voelker HU,Kapp M,et al.Glycolytic phenotype in breast cancer:activation of Akt,up-regulation of GLUT1,TKTL1 and down-regulation of M2PK[J].J Cancer Res Clin Oncol,2010,136(2):219-225.
  • 7Manda G,Nechifor MT,Neagu TM.Reactive oxygen species,cancer and anti-cancer therapies[J].Curr Chem Biol,2009,3(1):342-366.
  • 8Kennedy KM,Dewhirst MW.Tumor metabolism of lactate:the influence and therapeutic potential for MCT and CD147 regulation[J].Future Oncol,2010,6 (1):127-148.
  • 9Furuta E,Okuda H,Kobayashi A,et al.Metabolic genes in cancer:their roles in tumor progression and clinical implications[J].Biochim Biophys Acta,2010,1805(2):141-152.
  • 10Hafer ZT,Grassian AR,Song L,et al.Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment[J].Nature,2009,461(7260):109-113.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部